Related Experiment Video
Updated: Dec 24, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Anxiety and depression in patients who undergo a cerebrovascular procedure
Lauren Lombardo1, Richard Shaw2, Kathleen Sayles2
1The Valley Hospital, Ridgewood, NJ, USA. llombardo@neurosurgerynj.com.
Insights
Anxiety and depression negatively impact mental health outcomes 30 days after cerebrovascular procedures. However, these conditions did not affect long-term quality of life or other medical outcomes.
Area of Science:
- Neurology
- Psychiatry
- Health Outcomes Research
Background:
- Cerebrovascular procedures carry significant risks and potential impacts on patient well-being.
- Understanding the influence of pre-existing mental health conditions like anxiety and depression is crucial for comprehensive patient care.
Purpose of the Study:
- To investigate the relationship between pre-procedural anxiety and depression and quality of life outcomes following open and endovascular cerebrovascular procedures.
- To identify potential demographic and clinical factors associated with anxiety and depression in this patient population.
Main Methods:
- Retrospective analysis of 349 patients undergoing cerebrovascular procedures (aneurysm, AVM, hemorrhage, stenosis, stroke, angiogram).
- Correlation of pre-procedural anxiety/depression with Global Physical Health, Global Mental Health, and Modified Rankin Scale scores.
- Univariate and multivariate regression analyses adjusted for medical history and sociodemographics.
Main Results:
- 18% of patients reported anxiety or depression, more common in females and younger individuals.
- Patients with anxiety/depression had significantly lower mental health scores at 30 days post-procedure.
- No significant differences were observed in length of stay, mortality, physical health, functionality, or 6-month quality of life outcomes.
Conclusions:
- Pre-procedural anxiety and depression are associated with poorer mental health outcomes at 30 days post-cerebrovascular procedures.
- These mental health conditions did not appear to influence longer-term medical or functional recovery at six months.
Background:
Observe the relationship of anxiety and depression on quality of life outcomes after open and endovascular cerebrovascular procedures.
Methods:
We retrospectively analyzed 349 patients who underwent a procedure for aneurysm, arteriovenous malformation, intraparenchymal hemorrhage, carotid stenosis, acute stroke, and conventional catheter angiogram over three years at a community hospital. We correlated pre-procedural anxiety and depression with Global Physical Health, Global Mental Health, and Modified Rankin Scale scores. We performed univariate and multivariate linear and logistic regression analyses adjusting for past medical history and sociodemographic factors.
Results:
Anxiety or depression occurred in 18 % of patients. Patients with anxiety or depression were more likely to be female (81% vs 60.8%; p = 0.002) and younger (54 vs. 59 years old; p = 0.025). The groups did not differ in type or urgency of procedure, smoking or history of diabetes. Patients with anxiety or depression reported lower mental health scores at 30 days (45.1 vs 48.2; p = 0.002) post-procedure. In multivariate analyses, anxious or depressed patients had worse mental health scores at 30 days (t = - 2.893; p = 0.008) than those who did not have a history of anxiety or depression. There was no difference between groups in length of stay, mortality, physical health t-scores, functionality scores, or six month quality of life outcomes.
Conclusions:
Patients undergoing cerebrovascular procedures who self-reported anxiety or depression showed a significant difference in mental health outcomes at 30 days, but six month mental health and other medical and functional outcomes measures were similar to patients without these diagnoses.
Related Concept Videos
Aneurysm IV: Nursing Management
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Depression: Overview
CNS Depressants: Barbiturates and Benzodiazepines
Generalized Anxiety Disorder
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

